Login / Signup

Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients.

David BussePhilipp SimonLisa SchmittDavid PetroffChristoph DornArne DietrichMarkus ZeitlingerWilhelm HuisingaRobin MicheletHermann WriggeCharlotte Kloft
Published in: Clinical pharmacokinetics (2021)
EudraCT: 2012-004383-22.
Keyphrases
  • obese patients
  • bariatric surgery
  • gastric bypass
  • roux en y gastric bypass
  • weight loss
  • low dose
  • gram negative
  • adipose tissue
  • metabolic syndrome